Antifungal resistance in dermatophytes - review of the epidemiology, diagnostic challenges and treatment strategies for managing

Antifungal drug resistance Dermatophytosis Ringworm Tinea superficial mycoses trichophyton indotineae

Journal

Expert review of anti-infective therapy
ISSN: 1744-8336
Titre abrégé: Expert Rev Anti Infect Ther
Pays: England
ID NLM: 101181284

Informations de publication

Date de publication:
08 Aug 2024
Historique:
medline: 8 8 2024
pubmed: 8 8 2024
entrez: 8 8 2024
Statut: aheadofprint

Résumé

There is an increasing number of reports of Trichophyton indotineae infections. This species is usually poorly responsive to terbinafine. A literature search was conducted in May 2024. T. indotineae infections detected outside the Indian subcontinent are generally associated with international travel. Reports of local spread are mounting.As a newly identified dermatophyte species closely related to the When both terbinafine and itraconazole are ineffective, options include off-label triazoles (voriconazole and posaconazole). We present four patients responding to these newer triazoles. Ringworm (dermatophytosis, tinea) is a fungal infection of the skin, hair and nails that is commonly seen by primary and secondary healthcare providers. An estimated 20-25% of the global population is affected by this condition. In Europe and the United States, tineas are often treated empirically using over-the-counter medications, which can increase the risk of resistance development.While antifungal resistance is not a new problem, this topic has garnered the attention of physicians and researchers in recent years due to an outbreak from South Asia caused by a new pathogen known as

Autres résumés

Type: plain-language-summary (eng)
Ringworm (dermatophytosis, tinea) is a fungal infection of the skin, hair and nails that is commonly seen by primary and secondary healthcare providers. An estimated 20-25% of the global population is affected by this condition. In Europe and the United States, tineas are often treated empirically using over-the-counter medications, which can increase the risk of resistance development.While antifungal resistance is not a new problem, this topic has garnered the attention of physicians and researchers in recent years due to an outbreak from South Asia caused by a new pathogen known as

Identifiants

pubmed: 39114868
doi: 10.1080/14787210.2024.2390629
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Aditya K Gupta (AK)

Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Mediprobe Research Inc, London, ON, Canada.

Tong Wang (T)

Mediprobe Research Inc, London, ON, Canada.

Avantika Mann (A)

Mediprobe Research Inc, London, ON, Canada.

Shruthi Polla Ravi (S)

Mediprobe Research Inc, London, ON, Canada.

Mesbah Talukder (M)

Mediprobe Research Inc, London, ON, Canada.
School of Pharmacy, BRAC University, Dhaka, Bangladesh.

Sara A Lincoln (SA)

Bako Diagnostics, Alpharetta, GA, USA.

Hui-Chen Foreman (HC)

Bako Diagnostics, Alpharetta, GA, USA.

Baruch Kaplan (B)

Adelson School of Medicine, Ariel University, Ariel, Israel.

Eran Galily (E)

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Vincent Piguet (V)

Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.

Avner Shemer (A)

Department of Dermatology, Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Wayne L Bakotic (WL)

Bako Diagnostics, Alpharetta, GA, USA.

Classifications MeSH